PharmaNest Announces New Pre-Clinical and Clinical NASH Data to Be Presented at the AASLD – The Liver Meeting Digital Experience™ (TLMdX) 2021

NEXT STORY
Mustang Bio Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights
PREV STORY
Aileron Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clearside Announces Pricing of Public Offering of Common Stock

ALPHARETTA, Ga., March 07, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage ...

author_avatar
NASDAQ Market News

Eidos Therapeutics Appoints William Lis to Board of Directors

SAN FRANCISCO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), a ...

author_avatar
NASDAQ Market News

Admera Health Launches New Tests for Cancer Supportive Care and Liquid Biopsy, Now Provides a Comprehensive Portfolio of Oncology Products

SOUTH PLAINFIELD, N.J., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Today, Admera Health (www.admerahealth.com) announced ...

author_avatar
NASDAQ Market News